Exposure, sensitization, and mechanisms of fungus-induced asthma

Current Allergy and Asthma Reports

Volumn 3, Issue 5, 2003, Pages 430-437

  Kauffman, Henk F ^a   van der Heide, Sicco ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYSTEINE PROTEINASE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 4 RECEPTOR; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR; TOLL LIKE RECEPTOR;

AGING; AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; ALTERNARIA; ATOPY; BRONCHOPULMONARY ASPERGILLOMA; BRONCHUS HYPERREACTIVITY; CELL SURFACE; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; EPITHELIUM CELL; FUNGAL BIOMASS; FUNGUS SPORE; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNITY; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT MUCOSA; REVIEW; RISK ASSESSMENT; SENSITIZATION; TH2 CELL; ASTHMA; DEUTEROMYCETES; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY;

AIR MICROBIOLOGY; ASTHMA; ENVIRONMENTAL EXPOSURE; EPITHELIAL CELLS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MITOSPORIC FUNGI; RESPIRATORY MUCOSA; SPORES, FUNGAL;

EID: 0142058021     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-003-0080-z     Document Type: Review

References (77)

1. Diamond G, Legarda D, Ryan LK: The innate immune response of the respiratory epithelium. Immunol Rev 2000, 173:27-38.
2. Kauffman HF, Tomee JFC: Inflammatory cells and airway defense against Aspergillus fumigatus. Immunol Allergy Clin North Am 1999, 18:619-640.
3. Zureik M, Neukirch C, Leynaert B, et al.: Sensitization to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ 2002, 325:411-414.
4. Burge HA: An update on pollen and fungal spore aerobiology. J Allergy Clin Immunol 2002, 110:544-552.
5. Bush RK, Portnoy JM: The role and abatement of fungal allergens in allergic diseases. J Allergy Clin Immunol 2001, 107:S430-S440.
6. Kauffman HF, van der Heide S, Beaumont F, et al.: The allergenic and antigenic properties of spore extracts of Aspergillus fumigatus: a comparative study of spore extracts with mycelium and culture filtrate extracts. J Allergy Clin Immunol 1984, 73:567-573.
7. Sporik RB, Arruda LK, Woodfolk J, et al.: Environmental exposure to Aspergillus fumigatus allergen (Asp f I). Clin Exp Allergy 1993, 23:326-331.
8. Mitakakis TZ, Barnes C, Tovey ER: Spore germination increases allergen release from Alternaria. J Allergy Clin Immunol 2001, 107:388-390.
9. Takatori K, Lee H-J, Ohta T, Shida T: Composition of the house dust mycoflora in Japanese houses. In Health Implications of Fungi in Indoor Environments. Edited by Samson RA, Flannigan B, Flannigan ME, Verhoef AP. Amsterdam: Elsevier, 1994:93-101.
10. van der Heide S, van Aalderen WM, Kauffman HF, et al.: Clinical effects of air cleaners in homes of asthmatic children sensitized to pet allergens. J Allergy Clin Immunol 1999, 104:447-451.
11. Douwes J, van der Sluis B, Doekes G, et al.: Fungal extracellular polysaccharides in house dust as a marker for exposure to fungi: relations with culturable fungi, reported home dampness, and respiratory symptoms. J Allergy Clin Immunol 1999, 103:494-500.
12. Wilken-Jensen K, Gravesen S: Atlas of Moulds in Europe Causing Respiratory Allergy. Copenhagen: ASK Publishing; 1984:7-110.
13. Horner WE, Helbling A, Salvaggio JE, Lehrer SB: Fungal allergens. Clin Micribiol Rev 1995, 8:161-179.
14. Beaumont F, Kauffman HF, de Monchy JG, et al.: Volumetric aerobiological survey of conidial fungi in the North-East Netherlands. II. Comparison of aerobiological data and skin tests with mould extracts in an asthmatic population. Allergy 1985, 40:181-186.
15. Nikkels AH, Terstegge P, Spieksma FThM: Ten types of microscopically identifiable airborne fungal spores at Leiden, The Netherlands. Aerobiologia 1996, 12:107-112.
16. Shelton BG, Kirkland KH, Flanders WD, Morris GK: Profiles of airborne fungi in buildings and outdoor environments in the United States. Appl Environ Microbiol 2002, 68:1743-1753.
17. Dharmage S, Bailey M, Raven J, et al.: Prevalence and residential determinants of fungi within homes in Melbourne, Australia. Clin Exp Allergy 1999, 29:1481-1489.
18. Beguin H, Nolard N: Mold biodiversity in homes I: Air and surface analysis of 130 dwellings. Aerobiologia 1994, 10:157-166.
19. Howard WA: Incidence and clinical characteristics of mould allergy. In Mould Allergy. Edited by Al-Doory Y, Domson JF. Philadelphia: Lea and Febiger; 1984:147-156.
20. Heide Svd, Kauffman HF, De Vries K: Cultivation of fungi in synthetic and semi-synthetic liquid medium. II. Immunochemical properties of the antigenic and allergenic extracts. Allergy 1985, 40:592-598.
21. Gautrin D, Vandenplas O, Dewitte J-D, et al.: Allergenic exposure, IgE-mediated sensitization, and related symptoms in lawn cutters. J Allergy Clin Immunol 1994, 93:437-445.
22. D'Amato G, Spieksma FThM: Aerobiologic and clinical aspects of mold allergy in Europe. Allergy 1995, 50:870-877.
23. Zock JP, Jarvis D, Luczynska C, et al.: Housing characteristics, reported mold exposure, and asthma in the European Community Respiratory Health Survey. J Allergy Clin Immunol 2002, 110:285-292.
24. Salvaggio JE, Aukrust L: Mold-induced asthma. J Allergy Clin Immunol 1981, 68:327-346.
25. Niemeyer NR, de Monchy JGR: Age-dependency of sensitization to aero-allergens in asthmatics. Allergy 1992, 47:431-435.
26. Koivikko A, Viander M, Lanner A: Use of the extended Phadebas RAST panel in the diagnosis of mould allergy in asthmatic children. Allergy 1991, 46:85-91.
27. Kauffman HF, Tomee JF, van der Werf TS, et al.: Review of fungus-induced asthmatic reactions. Am J Respir Crit Care Med 1995, 151:2109-2115.
28. Nolles G, Hoekstra MO, Schouten JP, et al.: Prevalence of immunoglobulin E for fungi in atopic children. Clin Exp Allergy 2001, 31:1564-1570.
29. Ezeamuzie CI, Al Ali S, Khan M, et al.: IgE-mediated sensitization to mould allergens among patients with allergic respiratory diseases in a desert environment. Int Arch Allergy Immunol 2000, 121:300-307.
30. Dharmage S, Bailey M, Raven J, et al.: Current indoor allergen levels of fungi and cats, but not house dust mites, influence allergy and asthma in adults with high dust mite exposure. Am J Respir Crit Care Med 2001, 164:65-71.
31. Tariq SM, Matthews SM, Stevens M, Hakim EA: Sensitization to Alternaria and Cladosporium by the age of 4 years. Clin Exp Allergy 1996, 26:794-798.
32. Halonen M, Stern DA, Wright AL, et al.: Alternaria as a major allergen for asthma in children raised in a desert environment. Am J Respir Crit Care Med 1997, 155:1356-1361.
33. Neukirch C, Henry C, Leynaert B, et al.: Is sensitization to Alternaria alternata a risk factor for severe asthma? A population-based study. J Allergy Clin Immunol 1999, 103:709-711.
34. Black PN, Udi AA, Brodie SM: Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy 2000, 55:501-504.
35. Targonski PV, Persky VW, Ramekrishnan V: Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol 1995, 95:955-961.
36. Dales RE, Cakmak S, Burnett RT, et al.: Influence of ambient fungal spores on emergency visits for asthma to a regional children's hospital. Am J Respir Crit Care Med 2000, 162:2087-2090.
37. O'Hollaren MT, Yunginger JW, Offord KP, et al.: Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991, 324:359-363.
38. Downs SH, Mitakakis TZ, Marks GB, et al.: Clinical importance of Alternaria exposure in children. Am J Respir Crit Care Med 2001, 164:455-459.
39. Burch M, Leved E: Effects of meteorological conditions on spore plumes. Int J Biometeorol 2002, 46:107-117.
40. Medzhitov R, Janeway C Jr: The Toll receptor family and microbial recognition. Trends Microbiol 2000, 8:452-456.
41. Lemaitre B, Nicolas E, Michaut L, et al.: The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86:973-983.
42. Netea MG, Van Der Graaf CA, Vonk AG, et al.: The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated Candidiasis. J Infect Dis 2002, 185:1483-1489.
43. Morre SA, Murillo LS, Spaargaren J, et al.: Role of the toll-like receptor 4 Asp299Gly polymorphism in susceptibility to Candida albicans infection. J Infect Dis 2002, 186:1377-1379.
44. Mambula SS, Sau K, Henneke P, et al.: Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem 2002, 277:39320-39326.
45. Jones BW, Heldwein KA, Means TK, et al.: Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages. Ann Rheum Dis 2001, 60(Suppl3):iii6-iii12.
46. Kauffman HF: Immunopathogenesis of allergic bronchopulmonary aspergillosis and airway remodeling. Front Biosci 2003, 8:E190-E196.
47. Asokananthan N, Graham PT, Fink J, et al.: Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J Immunol 2002, 168:3577-3585.
48. Kauffman HF, Tomee JF, van de Riet MA, et al.: Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000, 105:1185-1193.
49. Thompson PJ: Unique role of allergens and the epithelium in asthma. Clin Exp Allergy 1998, 28:110-116.
50. Kauffman HF: Interaction of environmental allergens with airway epithelium as a key component of asthma. Curr Allergy Asthma Rep 2003, 3:101-108.
51. Holgate ST, Davies DE, Lackie PM, et al.: Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000, 105:193-204.
52. Kurup VP, Xia JQ, Shen HD, et al.: Alkaline serine proteinase from Aspergillus fumigatus has synergistic effects on Asp-f-2-induced immune response in mice. Int Arch Allergy Immunol 2002, 129:129-137.
53. Monod M, Jaton-Ogay K, Reichard U: Aspergillus fumigatus-secreted proteases as antigenic molecules and virulence factors. In Aspergillus fumigatus: Biology, Clinical Aspects and Molecular Approaches to Pathogenicity, edn 2. Edited by Brakhage AA, Jahn B, Schmidt A. Wuppertal, Germany: Axel Schmidt; 1999:182-192.
54. Tomee JF, Wierenga ATJ, Hiemstra PS, Kauffman HF: Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 1997, 176:300-303.
55. Murray CS, Woodcock A, Custovic A: The role of indoor allergen exposure in the development of sensitization and asthma. Curr Opin Allergy Clin Immunol 2001, 1:407-412.
56. Pearce N, Pekkanen J, Beasley R: How much asthma is really attributable to atopy? Thorax 1999, 54:268-272.
57. Sundeep SS, Babu KS, Holgate ST: Is asthma really due to a polarized T cell response toward a helper T cell type 2 phenotype? Am J Respir Crit Care Med 2001, 164:1333-1338.
58. Becky Kelly EA, Busse WW, Jarjour NN: A comparison of the airway response to segmental antigen bronchial provocation in atopic asthma and allergic rhinitis. J Allergy Clin Immunol 2003, 111:79-86.
59. Lopuhaa CE, Out TA, Jansen HM, et al.: Allergen induced bronchial inflammation in house dust mite allergic patients with and without asthma. Clin Exp Allergy 2003, In press.
60. Laitinen LA, Heino M, Laitinen A, et al.: Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985, 131:599-606.
61. Holgate ST: Inflammatory and structural changes in the airways of patients with asthma. Respir Med 2000, 94(SupplD):S3-S6.
62. Montefort S, Roberts JA, Beasley R, et al.: The site of disruption of the bronchial epithelium in asthmatic and non-asthmatic subjects. Thorax 1992, 47:499-503.
63. Tohda Y, Kubo H, Ito M, et al.: Histopathology of the airway epithelium in an experimental dual-phase model of bronchial asthma. Clin Exp Allergy 2001, 31:135-143.
64. Polosa R, Prosperini C, Tomaselli V, et al.: Expression of c-erbB receptors and ligands in human nasal epithelium. J Allergy Clin Immunol 2000, 106:1124-1131.
65. Puddicombe SM, Polosa R, Richter A, et al.: Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J 2000, 14:1362-1374.
66. Davies DE: The bronchial epithelium in chronic and severe asthma. Curr Allergy Asthma Rep 2001, 1:127-133.
67. Holgate ST, Lackie P, Wilson S, et al.: Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma. Am J Respir Crit Care Med 2000, 162:S113-S117.
68. Koppelman GH, Stine OC, Xu J, et al.: Genome-wide search for atopy susceptibility genes in Dutch families with asthma. J Allergy Clin Immunol 2002, 109:498-506.
69. Leung TF, Tang NL, Chan IH, et al.: A polymorphism in the coding region of interleukin-13 gene is associated with atopy but not asthma in Chinese children. Clin Exp Allergy 2001, 31:1515-1521.
70. Kruse S, Kuehr J, Moseler M, et al.: Polymorphisms in the IL-18 gene are associated with specific sensitization to common allergens and allergic rhinitis. J Allergy Clin Immunol 2003, 111:117-122.
71. Howard TD, Postma DS, Koppelman GA, et al.: Fine mapping of an IgE-controlling gene on chromosome 2q: analysis of CTLA4 and CD28. J Allergy Clin Immunol 2002, 110:743-751.
72. Howard TD, Wiesch DG, Koppelman GH, et al.: Genetics of allergy and bronchial hyperresponsiveness. Clin Exp Allergy 1999, 29(Suppl2):86-89.
73. Palmer LJ, Burton PR, Faux JA, et al.: Independent inheritance of serum immunoglobulin E concentrations and airway responsiveness. Am J Respir Crit Care Med 2000, 161:1836-1843.
74. Van Eerdewegh P, Little RD, Dupuis J, et al.: Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002, 418:426-430.
75. Holgate ST, Davies DE, Murphy G, et al.: ADAM 33: just another asthma gene or a breakthrough in understanding the origins of bronchial hyperresponsiveness? Thorax 2003, 58:466-469.
76. Howard TD, Koppelman GH, Xu J, et al.: Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet 2002, 70:230-236.
77. Knutsen AP, Bellone C, Kauffman HF: Immunopathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis. J Cystic Fibrosis 2002, 1:76-89.